STATISTICAL ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS IN CLINICAL STUDIES: EXPECTATIONS AND LIMITATIONS

被引:0
|
作者
Gillissen, A. [1 ]
Glaab, T. [2 ]
Lewis, M. [3 ]
Buhl, R. [2 ]
Worth, H.
机构
[1] Robert Koch Hosp, St George Med Ctr, Leipzig, Germany
[2] Univ Hosp, Dept Pulm, Mainz, Germany
[3] FISPE Epidemiol GmbH, Berlin, Germany
来源
关键词
chronic obstructive pulmonary disease; exacerbation; statistics; INHALED CORTICOSTEROIDS; LUNG-FUNCTION; FLUTICASONE PROPIONATE; COPD EXACERBATIONS; BETA-AGONISTS; MORTALITY; TIOTROPIUM; OUTCOMES; METAANALYSIS; SALMETEROL;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute exacerbations of chronic obstructive pulmonary disease (COPD) occur more frequently with increasing COPD severity and are associated with increased morbidity, reduced quality of life, and increased risk of mortality. The prevention and assessment of exacerbations, as a clinically and therapeutically relevant parameter, is a central aspect of clinical COPD studies. The aim of this review is to identify pittfalls in the analysis of the parameter of exacerbation and to describe the criteria that need to be considered in the statistical analysis of exacerbation studies.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 50 条
  • [31] Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
    Puhan, Milo
    Scharplatz, Madlaina
    Troosters, Thierry
    Walters, E. Haydn
    Steurer, Johann
    SAO PAULO MEDICAL JOURNAL, 2009, 127 (05): : 322 - 322
  • [32] Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
    Puhan, Milo
    Scharplatz, Madlaina
    Troosters, Thierry
    Walters, E. Haydn
    Steurer, Johann
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [33] Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
    Puhan, Milo A.
    Gimeno-Santos, Elena
    Cates, Christopher J.
    Troosters, Thierry
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (12):
  • [34] Exacerbations in Chronic Obstructive Pulmonary Disease: Clinical, Genetic, and Mycobiome Risk Factors
    Matsumoto, Kenki
    Read, Nicola
    Philip, Keir E. J.
    Allinson, James P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (04) : 487 - 489
  • [35] Clinical and laboratory parameters in assessing the risk of exacerbations in chronic obstructive pulmonary disease
    Kadushkin, A. G.
    Shman, T. V.
    Goncharik, A. V.
    Germenchuk, I. A.
    Kolb, A. V.
    Taganovich, A. D.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (03) : 10 - 16
  • [36] Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations
    Xiao, Wei
    Chen, Yi-long
    Du, Long-yi
    Wu, Jiqiu
    Wang, Zhang
    Mao, Bing
    Wen, Fu-qiang
    Gibson, Peter Gerard
    Mcdonald, Vanessa M.
    Yu, Haopeng
    Fu, Juan-juan
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [37] Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
    Puhan, Milo A.
    Gimeno-Santos, Elena
    Scharplatz, Madlaina
    Troosters, Thierry
    Walters, E. Haydn
    Steurer, Johann
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):
  • [38] Clinical Factors Affecting the Costs of Hospitalized Chronic Obstructive Pulmonary Disease Exacerbations
    Emre, Julide Celdir
    Ozdemir, Ozer
    Baysak, Aysegul
    Aksoy, Umit
    Ozdemir, Pelin
    Oz, Adnan Tolga
    Deniz, Sami
    EURASIAN JOURNAL OF PULMONOLOGY, 2014, 16 (03) : 180 - 183
  • [39] Prevalence and Clinical Significance of Fever in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    D. Lieberman
    O. Shmarkov
    Y. Gelfer
    R. Varshavsky
    D. V. Lieberman
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 75 - 78
  • [40] Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease
    Lieberman, D
    Shmarkov, O
    Gelfer, Y
    Varshavsky, R
    Lieberman, DV
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (02) : 75 - 78